Ke-Jian Gan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
Researchers at Massachusetts General Hospital and Harvard Medical School evaluated the effects of a combinatorial strategy involving the oncolytic herpes simplex virus (oHSV) G47驻 and the alkylating agent temozolomide (TMZ) on glioblastoma stem cells (GSCs). They found that combination of these agents synergistically killed GSCs and in mouse models of(More)
  • 1